SCHEMBL7512784

SCHEMBL7512784

O=C(O)/C(=N\O)c1cccs1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.57
CES2 O00748 1/20 0.54
CES1 P23141 1/20 0.54
HPGDS O60760 1/20 0.50
ERCC5 P28715 1/20 0.50
FEN1 P39748 1/20 0.50
ALDH1A1 P00352 5/20 0.49
MAPT P10636 2/20 0.49
RAB9A P51151 7/20 0.48
NPC1 O15118 6/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
LMNA P02545 2/20 0.48
POLB P06746 1/20 0.48
HDAC1 Q13547 1/20 0.48
HPGD P15428 4/20 0.46
ALOX15 P16050 1/20 0.46
GSK3B P49841 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
TP53 P04637 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7515206 1.00 DAO (0.57) DAOCES2CES1HPGDSERCC5
SCHEMBL7512791 1.00 DAO (0.57) DAOCES2CES1HPGDSERCC5
SCHEMBL13739852 0.89 CES2 (0.52) DAOCES2CES1HPGDSALDH1A1
SCHEMBL9769960 0.82 CES2 (0.52) DAOCES2CES1HPGDSALDH1A1
SCHEMBL11523638 0.82 CES2 (0.52) DAOCES2CES1HPGDSERCC5
SCHEMBL11523637 0.82 CES2 (0.52) DAOCES2CES1HPGDSERCC5
SCHEMBL2509540 0.82 HPGDS (0.58) DAOCES2CES1HPGDSALDH1A1
SCHEMBL2474971 0.82 HPGDS (0.58) DAOCES2CES1HPGDSALDH1A1
SCHEMBL18734641 0.79 DAO (0.67) DAOCES2CES1HPGDSERCC5
SCHEMBL11580725 0.78 DAO (0.50) DAOCES2CES1HPGDSERCC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1012139-B1 AZETIDINONE DERIVATIVES AS BETA-LACTAMASE INHIBITORS NAEJA PHARMACEUTICAL INC (CA) 2002-11-13 EP disclosed
EP-0979229-B1 2-OXO-1-AZETIDINE SULFONIC ACID DERIVATIVES AS POTENT BETA-LACTAMASE INHIBITORS NAEJA PHARMACEUTICAL INC (CA) 2002-10-23 EP disclosed
EP-1012139-A4 AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS NAEJA PHARMACEUTICAL INC (CA) 2001-08-16 EP disclosed
EP-1012139-A1 AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS Naeja Pharmaceutical Inc. (CA) 2000-06-28 EP disclosed
EP-0979229-A1 2-OXO-1-AZETIDINE SULFONIC ACID DERIVATIVES AS POTENT BETA-LACTAMASE INHIBITORS Naeja Pharmaceutical Inc. (CA) 2000-02-16 EP disclosed
US-5994340-A SYNERGISTIC MIXTURE WITH ANTIBIOTICS SYNPHAR LABORATORIES, INC. (CA) 1999-11-30 US disclosed
US-5888998-A INCREASE EFFECTIVENESS OF B-LACTAM ANTIBIOTICS SYNPHAR LABORATORIES, INC. (CA) 1999-03-30 US disclosed
WO-1999010324-A1 AZETIDINONE DERIVATIVES AS β-LACTAMASE INHIBITORS NAEJA PHARMACEUTICAL INC. (CA) 1999-03-04 WO disclosed
WO-1998047895-A1 2-OXO-1-AZETIDINE SULFONIC ACID DERIVATIVES AS POTENT β-LACTAMASE INHIBITORS NAEJA PHARMACEUTICAL INC. (US) 1998-10-29 WO disclosed
US-4385177-A Cephalosporins having a carbamoylalkoxyiminoarylacetamido group at 7-position GLAXO LABORATORIES, LTD. (GB) 1983-05-24 US disclosed